The FANCG gene (Fanconi Anemia Group G), also known as XRCC9, encodes a critical component of the Fanconi anemia (FA) DNA repair pathway. FANCG is a core member of the multi-subunit FA core complex, which functions as an E3 ubiquitin ligase necessary for the monoubiquitination of FANCD2 and FANCI— the central activating events in the repair of DNA interstrand crosslinks (ICLs) [liu2001]. The protein is characterized by multiple tetratricopeptide repeat (TPR) domains that mediate protein-protein interactions essential for assembly and function of the FA core complex.
FANCG mutations cause Fanconi anemia complementation group G (FA-G), characterized by congenital abnormalities, bone marrow failure, and predisposition to both hematological and solid malignancies. Given the pathway's fundamental role in maintaining genomic stability, FANCG has attracted significant attention for understanding DNA repair mechanisms and cancer predisposition syndromes [niedernhofer2007].
Beyond its well-established role in ICL repair, emerging evidence suggests that FANCG and other FA pathway proteins may contribute to neuronal survival in neurodegenerative diseases. The FA pathway's intersection with DNA repair, transcriptional regulation, and cellular stress response positions it as a potentially important player in age-related neurodegeneration [niraj2017].
| Gene Symbol | FANCG |
|---|---|
| Gene Name | Fanconi Anemia Group G (XRCC9) |
| Chromosome | 9p13.3 |
| NCBI Gene ID | 2188 |
| OMIM | 602956 |
| UniProt | O43272 |
| Ensembl ID | ENSG00000221838 |
| Protein Length | 622 amino acids |
| Associated Diseases | Fanconi Anemia, Alzheimer's Disease, Parkinson's Disease |
The FANCG gene is located on chromosome 9p13.3 and spans approximately 6.2 kb of genomic DNA consisting of 14 exons. The gene encodes a protein of 622 amino acids with a molecular weight of approximately 68 kDa. The gene promoter contains canonical TATA and CAAT box elements as well as binding sites for multiple transcription factors including Sp1 and p53, which regulate constitutive and stress-inducible expression.
The defining structural feature of FANCG is the presence of multiple tetratricopeptide repeat (TPR) domains throughout the protein [kim2018]. TPR domains are 34-amino acid repeating motifs that form amphipathic helices capable of mediating protein-protein interactions:
The TPR domains create a scaffold that organizes the FA core complex and facilitates proper positioning of catalytic components. Structural studies suggest that FANCG acts as a central hub connecting multiple FA core subunits.
FANCG shows conservation across vertebrates:
The TPR domain structure is particularly well-conserved, reflecting the fundamental importance of protein-protein interaction scaffolding in FA core complex assembly.
FANCG is an essential component of the FA core complex, a multi-subunit E3 ubiquitin ligase comprising FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM [reuter2018]. The complex assembles in response to DNA damage and is required for activation of the downstream FA pathway:
FANCG interacts with multiple proteins essential for FA pathway function:
| Partner Protein | Interaction Domain | Functional Consequence |
|---|---|---|
| FANCA | TPR1 (100-150) | Core complex stability |
| FANCF | TPR2 (200-280) | Heterodimer formation |
| FANCL | TPR3 (350-430) | E3 ligase recruitment |
| FANCD2 | C-terminal | Substrate presentation |
| XRCC1 | C-terminal | Backup ICL repair |
The FA core complex, including FANCG, is required for ICL repair through the following sequence [tani2019]:
FANCG contributes to this pathway by stabilizing the FA core complex and ensuring proper catalytic function. FANCG-deficient cells show severely impaired FANCD2 monoubiquitination and ICL repair capacity.
Biallelic FANCG mutations cause Fanconi anemia complementation group G (FA-G), accounting for approximately 9% of all FA cases [castella2015]:
FANCG patients typically present with a severe phenotype, reflecting the protein's critical role in the FA pathway. Genotype-phenotype correlations show that truncating mutations generally cause more severe disease than missense mutations that retain partial function.
While not traditionally classified as a neurodegeneration gene, FANCG may contribute to neuronal survival through several mechanisms [niraj2017]:
FANCG is expressed ubiquitously with highest levels in:
In the brain, FANCG is expressed in both neurons and astrocytes. The protein localizes to the nucleus where it participates in DNA repair functions. Expression is upregulated in response to DNA damage, consistent with its role in the DNA damage response.
FANCG intersects with several other DNA repair and signaling pathways:
Current therapeutic approaches for FA include:
The FA pathway's role in genomic stability has significant implications for cancer:
FANCG is an essential scaffold protein in the FA core complex, facilitating protein-protein interactions required for ICL repair and genomic stability.